Companies

23andMe - Failure Museum

23andMe

After peaking at an $8.5 billion valuation in the public market in 2021, 23andMe is at risk of being delisted from the Nasdaq in early 2024 as it's stock is down 96%. Security br ...

About Us

Failure Museum
A collection by Sean Jacobsohn of failed companies and products. Discover the causes of these failures and how to learn from them.

Categories